This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción ELNJ
Elanix Biotechnologies AG, a tissue regeneration company, engages in the development and commercialization of products for acute wound care.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Elanix Biotechnologies AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €0.011 |
| 52 Week High | €0.08 |
| 52 Week Low | €0.001 |
| Beta | 0 |
| 1 Month Change | -65.00% |
| 3 Month Change | n/a |
| 1 Year Change | -79.00% |
| 3 Year Change | -97.38% |
| 5 Year Change | -99.60% |
| Change since IPO | -99.60% |
Noticias y actualizaciones recientes
No hay actualizaciones
Recent updates
No hay actualizaciones
Rentabilidad de los accionistas
| ELNJ | DE Biotechs | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -1.2% | 1.7% |
| 1Y | -79.0% | -23.0% | 2.3% |
Rentabilidad vs. Industria: ELNJ underperformed the German Biotechs industry which returned -5.8% over the past year.
Rentabilidad vs. Mercado: ELNJ underperformed the German Market which returned 4% over the past year.
Volatilidad de los precios
| ELNJ volatility | |
|---|---|
| ELNJ Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: ELNJ's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine ELNJ's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | n/a | Lee-Ann Laurent-Applegate | www.elanixbiotechnologies.ch |
Resumen de fundamentos de Elanix Biotechnologies AG
| Estadísticas fundamentales de ELNJ | |
|---|---|
| Capitalización bursátil | €428.29k |
| Beneficios(TTM) | -€4.46m |
| Ingresos (TTM) | €280.19k |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está ELNJ sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ELNJ | |
|---|---|
| Ingresos | €280.19k |
| Coste de los ingresos | €348.59k |
| Beneficio bruto | -€68.39k |
| Otros gastos | €4.39m |
| Beneficios | -€4.46m |
Últimos beneficios comunicados
Jun 30, 2018
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado ELNJ a largo plazo?
Ver rendimiento histórico y comparativa